GeneTether Therapeutics (XCNQ:GTTX) Pre-Tax Income : C$-0.93 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. GeneTether Therapeutics's pretax income for the three months ended in Dec. 2023 was C$-0.42 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.93 Mil. GeneTether Therapeutics's pretax margin was %.

GeneTether Therapeutics Pre-Tax Income Historical Data

The historical data trend for GeneTether Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics Pre-Tax Income Chart

GeneTether Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-0.09

-2.10

-2.33

-0.92

GeneTether Therapeutics Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial								-0.51	-0.28	-0.19	-0.04	-0.42

Competitive Comparison of GeneTether Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, GeneTether Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneTether Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneTether Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where GeneTether Therapeutics's Pre-Tax Income falls into.

GeneTether Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

GeneTether Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.002	+	0.009	+	0	+	0.07	+	0
	=	-0.92

GeneTether Therapeutics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.455	+	0.009	+	0	+	0.021	+	0.001
	=	-0.42

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.93 Mil.

GeneTether Therapeutics (XCNQ:GTTX) Pre-Tax Income Explanation

GeneTether Therapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.424	/	0
	=	%

GeneTether Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneTether Therapeutics (XCNQ:GTTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3

Website

https://www.genetether.com

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines